What is NDC 65862-248?

65862-248 is the product NDC for Escitalopram Oxalate, Escitalopram oxalate 5 mg/5mL solution, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Escitalopram Oxalate?

40 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Escitalopram Oxalate NDC 65862-248 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-248Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0248Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65862-248-24	65862024824	240 mL in 1 BOTTLE (65862-248-24)Marketed from Apr 3, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Escitalopram Oxalate
Generic name (nonproprietary): escitalopram oxalate
Active ingredients: Escitalopram oxalate — 5 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 65862
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 079062
Marketing start: Apr 3, 2012
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 65862-248_a8ce07ef-c51d-4af2-bafb-b0a32c090431SPL ID a8ce07ef-c51d-4af2-bafb-b0a32c090431SPL set ID ba60c357-8e61-4a3d-b1dc-25602dbbfc2aRxCUI 351285UNII 5U85DBW7LO
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862024824 followed by a unit qualifier and the quantity

Package 65862-0248-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 4, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Escitalopram oral solution is indicated for the treatment of: major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older. generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older. Escitalopram oral solution is a selective serotonin reuptake inhibitor (SSRI) indicated for the: treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older ( 1 ) treatment of generalized anxiety disorder (GAD) in adults and pediatric patients 7 years and older ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65862-248

What is NDC 65862-248?: 65862-248 is the product NDC for Escitalopram Oxalate, Escitalopram oxalate 5 mg/5mL solution, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Escitalopram Oxalate.
What is the active ingredient?: Escitalopram oxalate.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Escitalopram Oxalate?: 40 other product NDCs are listed under this name. See all Escitalopram Oxalate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Escitalopram Oxalate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Escitalopram Oxalateescitalopram	Escitalopram oxalate 10 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4703	70518-4703-00
Escitalopram Oxalateescitalopram	Escitalopram oxalate 5 mg/1	TabletOral	Ascent Pharmaceuticals, Inc	43602-473	43602-0473-1043602-0473-30
Escitalopram Oxalateescitalopram	Escitalopram oxalate 10 mg/1	TabletOral	Ascent Pharmaceuticals, Inc	43602-474	43602-0474-1043602-0474-30
Escitalopram Oxalateescitalopram	Escitalopram oxalate 20 mg/1	TabletOral	Ascent Pharmaceuticals, Inc	43602-475	43602-0475-1043602-0475-30
Escitalopram Oxalate	Escitalopram oxalate 20 mg/21	Tablet, Film coatedOral	A-S Medication Solutions	50090-7200	50090-7200-0050090-7200-01
Escitalopram Oxalate	Escitalopram oxalate 20 mg/21	Tablet, Film coatedOral	A-S Medication Solutions	50090-7201	50090-7201-00
Escitalopram Oxalate	Escitalopram oxalate 5 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-149	72603-0149-01
Escitalopram Oxalate	Escitalopram oxalate 10 mg/21	Tablet, Film coatedOral	NorthStar RxLLC	72603-150	72603-0150-01
Escitalopram Oxalate	Escitalopram oxalate 20 mg/21	Tablet, Film coatedOral	NorthStar RxLLC	72603-151	72603-0151-01
escitalopram oxalate	Escitalopram oxalate 5 mg/1	TabletOral	Quallent Pharmaceuticals Health LLC	82009-035	82009-0035-10

All 41 Escitalopram Oxalate NDCs

Other NDCs under ANDA 079062

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 079062
Product	Strength	Form · route	Labeler	Product NDC
Escitalopram Oxalate	Escitalopram oxalate 5 mg/5mL	SolutionOral	Rising Pharma Holdings, Inc.	16571-769